High-quality cancer care must include palliative care in addition to the more traditional care, such as oncology, radiology, surgery, and imaging, Toby C. Campbell, MD, MSCI, associate professor of medicine, hematology-oncology at the University of Wisconsin School of Medicine and Public Health and chief of Palliative Care and program director of the Hospice and Palliative Medicine Fellowship Training Program, said at the National Comprehensive Cancer Network Annual Conference.
High-quality cancer care must include palliative care in addition to the more traditional care, such as oncology, radiology, surgery, and imaging, Toby C. Campbell, MD, MSCI, associate professor of medicine, hematology-oncology at the University of Wisconsin School of Medicine and Public Health and chief of Palliative Care and program director of the Hospice and Palliative Medicine Fellowship Training Program, said at the National Comprehensive Cancer Network Annual Conference.
Transcript (slightly modified)
What has been a key takeaway from the NCCN meeting regarding the discussion on palliative care?
What we've been talking about at NCCN here is the highest quality cancer care and it's really clear that if you want to deliver high-quality cancer care, that includes not only the traditional components like good oncology and radiology and surgery and imaging, but also palliative care. And palliative care delivered by a multi-disciplinary team, which might include a physician and nurse practictioner, but also a social worker or nurse, and that kind of resources that are brought to bear for a patient and family really are a core component of high-quality cancer care.
Do you find the topic of palliative care is more commonly brought up by a nurse or other caregiver on the patient's team?
Palliative care comes up in a variety of circumstances. Sometimes it's the nurse in the chemotherapy room. Sometimes it's the provider. So I think discussions of a palliative nature come up in lots of different contexts. Sometimes it rises to the level where a subspecialists in palliative care becomes a part of the team. And that, too, can be brought up by any number of individuals, including the patients and families themselves.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More